Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bateman

Showing results (291-300 of 533) with videos related to

Pageof 54
Sort By:
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S Research & Therapy|May 25, 2023
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir studyAntoinette O'Connor, David M Cash, Teresa Poole, et al.
The New England Journal of Medicine|November 30, 2022
Lecanemab in Early Alzheimer's DiseaseChristopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaquesShveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Cell Stem Cell|June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neuronsLucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
Plos One|June 8, 2012
In vivo human apolipoprotein E isoform fractional turnover rates in the CNSKristin R Wildsmith, Jacob M Basak, Bruce W Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Science Translational Medicine|July 1, 2011
Human apoE isoforms differentially regulate brain amyloid-β peptide clearanceJoseph M Castellano, Jungsu Kim, Floy R Stewart, et al.
Annals of Neurology|September 11, 2014
Amyloid-β efflux from the central nervous system into the plasmaKaleigh Filisa Roberts, Donald L Elbert, Tom P Kasten, et al.
Pageof 54

Showing results (291-300 of 533) with videos related to

Sort By:
Pageof 54
Molecular Neurodegeneration|May 2, 2021
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysisTim West, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S Research & Therapy|May 25, 2023
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir studyAntoinette O'Connor, David M Cash, Teresa Poole, et al.
The New England Journal of Medicine|November 30, 2022
Lecanemab in Early Alzheimer's DiseaseChristopher H van Dyck, Chad J Swanson, Paul Aisen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 2, 2023
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaquesShveta Bathla, Dibyadeep Datta, Feng Liang, et al.
Cell Stem Cell|June 6, 2022
Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neuronsLucia S Capano, Chihiro Sato, Elena Ficulle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 23, 2023
Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN studyYing Xu, Htein Linn Aung, Randall J Bateman, et al.
Plos One|June 8, 2012
In vivo human apolipoprotein E isoform fractional turnover rates in the CNSKristin R Wildsmith, Jacob M Basak, Bruce W Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2017
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset formsCarlos Cruchaga, Jorge L Del-Aguila, Benjamin Saef, et al.
Science Translational Medicine|July 1, 2011
Human apoE isoforms differentially regulate brain amyloid-β peptide clearanceJoseph M Castellano, Jungsu Kim, Floy R Stewart, et al.
Annals of Neurology|September 11, 2014
Amyloid-β efflux from the central nervous system into the plasmaKaleigh Filisa Roberts, Donald L Elbert, Tom P Kasten, et al.
Pageof 54